Bristol-Myers Squibb (BMY) PT Raised At BMO On Combination With Celgene

March 20, 2019 6:51 AM
BMO Capital analyst, Alex Arfaeil, reiterated his Outperform rating on shares of Bristol-Myers Squibb Co. (NYSE: BMY) and raised the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles